These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33517425)

  • 1. Neurite Outgrowth Inhibitor (NogoA) Is Upregulated in White Matter Lesions of Complex Cortical Malformations.
    Scholl T; Gruber VE; Samueli S; Lehner R; Kasprian G; Czech T; Reinten RJ; Hoogendijk L; Hainfellner JA; Aronica E; Mühlebner A; Feucht M
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):274-282. PubMed ID: 33517425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired oligodendroglial turnover is associated with myelin pathology in focal cortical dysplasia and tuberous sclerosis complex.
    Scholl T; Mühlebner A; Ricken G; Gruber V; Fabing A; Samueli S; Gröppel G; Dorfer C; Czech T; Hainfellner JA; Prabowo AS; Reinten RJ; Hoogendijk L; Anink JJ; Aronica E; Feucht M
    Brain Pathol; 2017 Nov; 27(6):770-780. PubMed ID: 27750396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Nogo-A system in cortical lesions of pediatric patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Yu SX; Li S; Shu HF; Zhang CQ; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2012 Jul; 71(7):665-77. PubMed ID: 22710967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
    J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell injury and premature neurodegeneration in focal malformations of cortical development.
    Iyer A; Prabowo A; Anink J; Spliet WG; van Rijen PC; Aronica E
    Brain Pathol; 2014 Jan; 24(1):1-17. PubMed ID: 23586324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.
    Yao K; Duan Z; Zhou J; Li L; Zhai F; Dong Y; Wang X; Ma Z; Bian Y; Qi X; Li L
    Oncotarget; 2016 Nov; 7(47):76415-76422. PubMed ID: 27811355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
    Veersema TJ; de Neef A; van Scheppingen J; Ferrier CH; van Eijsden P; Gosselaar PH; van Rijen PC; Spliet WGM; Braun KPJ; Mühlebner A; Aronica E
    Int J Dev Neurosci; 2019 Dec; 79():96-104. PubMed ID: 31770571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tuberin and hamartin in tuberous sclerosis complex-associated and sporadic cortical dysplasia of Taylor's balloon cell type.
    Grajkowska W; Kotulska K; Matyja E; Larysz-Brysz M; Mandera M; Roszkowski M; Domańska-Pakieła D; Lewik-Kowalik J; Jóźwiak S
    Folia Neuropathol; 2008; 46(1):43-8. PubMed ID: 18368626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives.
    Mühlebner A; Bongaarts A; Sarnat HB; Scholl T; Aronica E
    J Anat; 2019 Sep; 235(3):521-542. PubMed ID: 30901081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J; Broekaart DW; Scholl T; Zuidberg MR; Anink JJ; Spliet WG; van Rijen PC; Czech T; Hainfellner JA; Feucht M; Mühlebner A; van Vliet EA; Aronica E
    J Neuroinflammation; 2016 Aug; 13(1):202. PubMed ID: 27566410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
    Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, imaging, and immunohistochemical characteristics of focal cortical dysplasia Type II extratemporal epilepsies in children: analyses of an institutional case series.
    Knerlich-Lukoschus F; Connolly MB; Hendson G; Steinbok P; Dunham C
    J Neurosurg Pediatr; 2017 Feb; 19(2):182-195. PubMed ID: 27885945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA; Ali AM; Tata M; Picker SR; Anderson GW; Latimer-Bowman E; Nicholson SL; Harkness W; Cross JH; Paine SM; Jacques TS
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NogoA Neutralization Promotes Axonal Restoration After White Matter Injury In Subcortical Stroke.
    Otero-Ortega L; Gómez-de Frutos MC; Laso-García F; Sánchez-Gonzalo A; Martínez-Arroyo A; Díez-Tejedor E; Gutiérrez-Fernández M
    Sci Rep; 2017 Aug; 7(1):9431. PubMed ID: 28842591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.
    Toering ST; Boer K; de Groot M; Troost D; Heimans JJ; Spliet WG; van Rijen PC; Jansen FE; Gorter JA; Reijneveld JC; Aronica E
    Epilepsia; 2009 Jun; 50(6):1409-18. PubMed ID: 19220410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal maturation and differentiation of neocortical neurons in epileptogenic cortical malformation: unique distribution of layer-specific marker cells of focal cortical dysplasia and hemimegalencephaly.
    Arai A; Saito T; Hanai S; Sukigara S; Nabatame S; Otsuki T; Nakagawa E; Takahashi A; Kaneko Y; Kaido T; Saito Y; Sugai K; Sasaki M; Goto Y; Itoh M
    Brain Res; 2012 Aug; 1470():89-97. PubMed ID: 22759905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.